Literature DB >> 11128654

The cost of COX inhibitors: how selective should we be?

C A Marra, J M Esdaile, H Sun, A H Anis.   

Abstract

Mesh:

Substances:

Year:  2000        PMID: 11128654

Source DB:  PubMed          Journal:  J Rheumatol        ISSN: 0315-162X            Impact factor:   4.666


× No keyword cloud information.
  3 in total

Review 1.  Selective COX-2 inhibitors: a health economic perspective.

Authors:  David L B Schwappach; Christian M Koeck
Journal:  Wien Med Wochenschr       Date:  2003

Review 2.  International variation in resource utilisation and treatment costs for rheumatoid arthritis: a systematic literature review.

Authors:  Hubertus Rosery; Rito Bergemann; Stefanie Maxion-Bergemann
Journal:  Pharmacoeconomics       Date:  2005       Impact factor: 4.981

3.  Encouraging physician appropriate prescribing of non-steroidal anti-inflammatory therapies: protocol of a randomized controlled trial [ISRCTN43532635].

Authors:  Malcolm Doupe; Alan Katz; Brent Kvern; Lori-Jean Manness; Colleen Metge; Glen T D Thomson; Laura Morrison; Kat Rother
Journal:  BMC Health Serv Res       Date:  2004-08-24       Impact factor: 2.655

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.